Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
6
×
clinical trials
fda
life sciences
national blog main
national top stories
allergan
biotech
boston blog main
boston top stories
eli lilly
new york blog main
national
new york top stories
amgen
astrazeneca
avexis
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
celgene
detroit blog main
detroit top stories
europe blog main
genentech
indiana blog main
indiana top stories
johnson & johnson
merck
microbiome
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
What
fda
6
×
treatment
approved
drug
new
bio
disease
news
nod
roundup
won
acorda
adults
alkermes
allergan
antipsychotic
approves
august
benefit
benefits
biotech
busy
caveats
class
commonly
companies
cope
days
decisions
designed
devices
digital
drop
drops
drugs
effect
epidemic
episodes
eye
fatty
Language
unset
Current search:
abbvie
×
fda
×
@extremetech.com
2 years ago
FDA Approves New Eye Drops that Could Replace Glasses for Millions
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms